Chemokines and left ventricular function in patients with acute myocardial infarction

European Journal of Internal Medicine

Volumn 18, Issue 4, 2007, Pages 288-294

  Kobusiak Prokopowicz, Małgorzata ^a   Orzeszko, Jacek ^a   Mazur, Grzegorz ^a   Mysiak, Andrzej ^a   Orda, Alina ^a   Poreba, Rafal ^a   Mazurek, Walentyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute myocardial infarction; MCP 1; MIP 1 ; RANTES

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MOVEMENT; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE; MALE; ST SEGMENT;

EID: 34250179893     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.02.001     Document Type: Article

References (21)

1. Shah P.K. Circulating markers of inflammation for vascular risk prediction: are they ready for prime time. Circulation 101 (2000) 1758-1759
2. Tsousoulis D., Davies G., Stefanadis C., Toutouzas P., and Ambrose J.A. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 89 (2003) 993-997
3. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., and Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96 (1997) 396-399
4. Shah P.K. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 3 (1998) 199-206
5. Meisel S.R., Shapiro H., Radnay J., Neuman Y., Khaskia A.R., Gruener N., et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligano ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. Possible implications for leukocyte aggregation and microvascular plugging. J Am Coll Cardiol 31 (1998) 120-125
6. Ridker P.M. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 10 suppl. 1 (1999) S9-S12
7. Mendall M.A., Strachan D.P., Butland B.K., Ballam L., Morris J., Sweetnam P.M., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factor in men. Eur Heart J 21 (2000) 1584-1590
8. Albert C.M., Ma J., Rafai N., Stampfer M.J., and Ridker P.M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 (2002) 2595-2599
9. Mueller Ch., Buettner H.J., Hodgson J.M., Marsch S., Perruchoud A.P., Roskamm H., et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 105 (2002) 1412-1415
10. Pietila K.O., Harmoinen A.P., Jokiniitty J., and Pasternack A.I. Serum C-reactive protein concentration in acute myocardial infarction and its relation to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17 (1996) 1345-1349
11. Anzai T., Yoshikawa T., Shiraki H., Asakura Y., Akaishi M., Mitamura H., et al. C-reactive protein as a predictor of infarct expansion an cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
12. Mazzone A., De Servi S., Mazzucchelli I., Bossi I., Ottini E., Vezzoli M., et al. Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T. Heart 85 (2001) 571-575
13. Liuzzo G., Baisucci L.M., Gallimore J.R., Caligiuri G., Buffon A., Rebuzzi A.G., et al. Enhanced inflammatory response in in patients with preinfarction unstable angina. J Am Coll Cardiol 34 (1999) 1696-1703
14. Viedt Ch., Vogel J., Athanasiou T., Shen W., Orth S.R., Kubler W., et al. MCP-1 induces interleukin-6 in human vascular smooth muscle cells through activation of transcription factors NF-kB and AP-1. J Am Coll Cardiol 37 suppl. A (2001) 850 [abstract]
15. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
16. Chen Y.L., Chang Y.J., and Jiang M.J. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Atherosclerosis 143 (1999) 115-123
17. B. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 (1999) 773-778
18. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
19. Engstrom G., Lind P., Hedblad B., Wollmer P., Stavenow L., Janzon L., et al. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 105 (2002) 2632-2637
20. Parissis J.T., Adamopoulos S., Venetsanou K.F., Mentzikof D.G., Karas S.M., and Kremastinos D.T. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res 22 (2002) 223-229
21. Kobusiak-Prokopowicz M., Orzeszko J., Mazur G., Mysiak A., Orda A., and Mazurek W. Kinetics of chemokines in acute myocardial infarction. Kardiol Pol 62 (2005) 301-314